CCRM: Building A Global Regenerative Medicine Ecosystem From Canadian Roots

The Centre for Commercialization of Regenerative Medicine has spent over a decade crafting a cell and gene therapy ecosystem in Canada. Now it is replicating the model abroad.

(Shutterstock)

Building a sustainable ecosystem requires more than just scientific excellence—it demands a coordinated approach to manufacturing, capital access, and talent development. The Centre for Commercialization of Regenerative Medicine (CCRM) has spent over a decade crafting such an ecosystem for the cell and gene therapy (CGT) space in Canada and is now replicating its model far beyond Canadian borders.

More from Manufacturing Focus

Q&A: Rentschler’s CEO On The CDMO’s Pivot Away From Cell And Gene Therapy And More

 
• By 

Rentschler Biopharma CEO Benedikt von Braunmühl tells In Vivo about the CDMO's strategic decision to exit the cell and gene therapy manufacturing space.

CCRM: Building A Global Regenerative Medicine Ecosystem From Canadian Roots

 
• By 

The Centre for Commercialization of Regenerative Medicine has spent over a decade crafting a cell and gene therapy ecosystem in Canada. Now it is replicating the model abroad.

Artiva Leverages Unmodified NK Cells To Challenge CAR-T Paradigm

 
• By 

Artiva Biotherapeutics is hoping its NK cell therapy approach, which uses un-engineered cells, will prove effective in both oncologic and autoimmune indications and safe enough to be given in the community setting.

New Manufacturing Technologies Are Here – What's Stopping Their Implementation?

 

Pharmaceutical manufacturing is developing at a lightning pace as the confluence of automation and AI creates opportunities for much higher efficiency and throughput. Experts from across the industry discuss these, and the challenges around implementation and standardization.

More from New Science

Neurodegenerative Disease Investment: Shifting Paradigms Beyond Amyloid And Tau

 
• By 

Companies are exploring new mechanisms of action beyond traditional amyloid and tau and both investors and big pharma are willing to make deals when the science is compelling, panelists at Biotech Showcase said.

Google Co-Authored Report Lays Out Roadmap For AI In Tackling AMR

 
• By 

Close collaboration between industry, academia and government in employing artificial intelligence could solve the looming threat of antimicrobial resistance, a new report co-authored by Google says.

Orano Med And Molecular Partners Transform Thorium Into Cancer Therapy

 
• By 

Swiss firm Molecular Partners and French national offshoot Orano Med have partnered to develop a potent new class of radiopharmaceuticals.